Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Peterson Katharine had 99 Acrivon Therapeutics, Inc. shares withheld for tax (Form 4)

Traded May 14, 2026 · Filed May 18, 2026

On May 14, 2026, Peterson Katharine (Chief Accounting Officer) had 99 Acrivon Therapeutics, Inc. shares withheld for tax at US$1.92 for US$190, leaving 3,907 shares. Filed May 18, 2026 (Form 4).

Withheld for tax
99 shares
Price
US$1.92
Value
US$190
Holding after
3,907 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockShares withheld for tax99US$1.923,907Direct

Source

View original at SEC

Related